S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS

• Olivier Demaria,
• Guillaume Habif,
• Francois Le Floch,
• Marianna Muller,
• Laura Chiossone,
• Romain Remark,
• Marie Vetizou,
• Nadia Maurel,
• Ariane Morel,
• Laurent Gauthier,
• Yannis Morel,
• Carine Paturel,
• Eric Vivier

Affiliations

Olivier Demaria

1 Innate Pharma, Marseille, France

Guillaume Habif

1 Innate Pharma, Marseille, France

Francois Le Floch

1 Innate Pharma, Marseille, France

Marianna Muller

1 Innate Pharma, Marseille, France

Laura Chiossone

1 Innate Pharma, Marseille, France

Romain Remark

1 Innate Pharma, Marseille, France

Marie Vetizou

1 Innate Pharma, Marseille, France

Nadia Maurel

1 Innate Pharma, Marseille, France

Ariane Morel

1 Innate Pharma, Marseille, France

Laurent Gauthier

1 Innate Pharma, Marseille, France

Yannis Morel

1 Innate Pharma, Marseille, France

Carine Paturel

1 Innate Pharma, Marseille, France

Eric Vivier

1 Innate Pharma, Marseille, France